Merck | MRK - Cash And Equivalent

Stock Price
123.90
Daily Change
0.05 0.04%
Monthly
-1.98%
Yearly
-12.90%
Q1 Forecast
121.85

Merck reported EUR1.17B in Cash and Equivalent for its fiscal quarter ending in June of 2025.





Cash And Equivalent Change Date
Adidas EUR 1.03B 263M Sep/2025
Adyen EUR 9.97B 1.23B Dec/2024
Akzo Nobel EUR 1.55B 47M Jun/2025
Alcon AG USD 1.5B 90M Sep/2025
Amadeus IT EUR 968.2M 525.2M Sep/2025
Amarin USD 122.8M 25.08M Sep/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
BASF EUR 1.86B 658M Sep/2025
Bayer EUR 5.9B 1.34B Sep/2025
Beiersdorf EUR 1.17B 40M Jun/2025
Covestro EUR 604M 115M Sep/2025
Danone EUR 1.62B 144M Jun/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.26B 459.13M Sep/2025
Galapagos EUR 64.46M 43.61M Sep/2025
Genmab DKK 1.3B 323M Jun/2025
Givaudan CHF 603M 3M Jun/2024
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Infineon EUR 1.36B 77M Sep/2025
Linde USD 4.51B 277M Sep/2025
Lonza CHF 1.11B 286M Dec/2024
Merck EUR 1.17B 161M Jun/2025
Novartis USD 9.56B 2.9B Sep/2025
Philips EUR 1.91B 90M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
UCB EUR 1.57B 1.14B Dec/2024